Page 22 - Journal of Special Operations Medicine - Spring 2015
P. 22

rapid  decrease in atmospheric pressure. Even recently,   limb numbness were most commonly noted in 133 cases
          the US Air Force has encountered severe DCS with high­  of altitude DCS Type II reviewed by Wirjosemito and
          altitude operations involving the U­2 airframe. 4  colleagues at the US Air Force School of Aerospace
                                                             Medicine.  Of these cases, 94.7% were due to altitude­
                                                                      6
          DCS results when dissolved gases (particularly nitro­  chamber training. In US Navy divers, 0.5% of Type
          gen) in the blood and tissues come out of solution due   II cases presented with unconsciousness.  Rapidity of
                                                                                                 7
          to a state of decreased partial pressure surrounding the   symptom onset following decompression is not related
          body. These gases form bubbles, which result in a typi­  to the differentiation of Type I versus Type II DCS but is
          cal constellation of symptoms depending on their loca­  related to severity of illness. Denial is common and ca­
          tion (Table 1).                                    sualties will often attribute their symptoms to anything
                                                             but  DCS. Three­quarters  of  DCS  casualties  develop
          Table 1  Signs and Symptoms of Decompression Sickness  clinical symptoms within 1 hour of decompression, and
                                                                                                            8
           Fatigue                                           overall 90% will develop symptoms within 12 hours.
           Pruritus                                          Very few develop symptoms more than 24 hours after
                                                             decompression.
           Skin rash (usually macular)
           Musculoskeletal pain (often of the joints)        Risk factors for DCS have been best studied in the under­
           Lymphadenopathy                                   water diving community and are listed in Table 2. 9,10  DCS
           *Headache                                         risk is increased in divers who either dive at an elevated
           *Vertigo/lightheadedness                          altitude or ascend to altitude following their dive. Div­
                                                             ers should wait at least 12 hours before flying if making
           *Numbness/tingling
                                                             only one dive per day. Those who require decompression
           *Extremity paralysis                              stops during the dive or who participate in multiple dives
           *Dyspnea                                          should wait at least 48 hours before flying. 8,11
           *Pharyngeal irritation (“chokes”)
                                                             Table 2  Decompression Sickness Risk Factors
           *Hemoptysis
           *Chest pain                                        Short decompression time (rapid exposure)
           *Memory loss                                       Vigorous exercise following exposure
           *Changes in affect, speech, or personality         Higher body­fat content
           *Ataxia (“staggers”)                               Dehydration
           *Visual disturbances                               Alcohol consumption
           *Loss of sphincter control (particularly bladder)  Increasing age
           *Unconsciousness                                   Male sex
           *Death                                             Inexperience (for divers)
          Note: *Items are more likely to correlate with a diagnosis of type II   Repetitive exposures to pressure change
          decompression sickness.                             Diving at attitude
                                                              Ascending to altitude after diving
          Golding and colleagues introduced the traditional clas­
          sification system in 1960.  Type I DCS is defined as
                                 5
          involving the skin, lymphatics, or musculoskeletal sys­  It should be noted that DCS is technically a separate en­
          tem. Type I symptoms are most commonly associated   tity from air or gas embolism (AGE), whereby gas bub­
          with DCS in the at­risk population. Indeed, joint pains   bles form in the blood and may occlude venous return
          were  the  predominating  symptom  in  60% to  70%  of   or arterial flow, depending on their location in the body.
          altitude DCS cases. Type I DCS does not necessarily re­  This technical difference from DCS, where bubbles may
          quire recompression and is not generally considered life   form in the tissues themselves, is not particularly rel­
          threatening.                                       evant to the treating provider in the field. The presenta­
                                                             tion of the casualty may be very similar to DCS and the
          By contrast, Type II DCS is typically viewed as more seri­  treatment is the same. Often, these diseases are clustered
          ous, with organ involvement such as pulmonary or neu­  under the category of dysbarisms.
          rologic manifestations that require urgent and aggressive
          intervention. Between 10% and 15% of DCS cases are   Case Continued
          categorized as type II. While divers typically are affected
          in the spinal cord, aviators are more likely to have cere­  Nursing disrobed the patient and placed him in a gown.
          bral manifestations. Headache, visual disturbance,  and    They applied the cardiac monitor, pulse oximeter, and



          12                                      Journal of Special Operations Medicine  Volume 15, Edition 1/Spring 2015
   17   18   19   20   21   22   23   24   25   26   27